EFFICACY OF RASAGILINE ON PROGRESSIVE DOPAMINE NEURON DEGENERATION AND NEUROINFLAMMATION IN A CHRONIC MPTPP MODEL OF PARKINSON'S DISEASE (Abstract/Poster in convegno)

Type
Label
  • EFFICACY OF RASAGILINE ON PROGRESSIVE DOPAMINE NEURON DEGENERATION AND NEUROINFLAMMATION IN A CHRONIC MPTPP MODEL OF PARKINSON'S DISEASE (Abstract/Poster in convegno) (literal)
Anno
  • 2014-01-01T00:00:00+01:00 (literal)
Alternative label
  • P. Porceddu(1), A. Pinna(2), L. Frau(1), M. Morelli(3) (2014)
    EFFICACY OF RASAGILINE ON PROGRESSIVE DOPAMINE NEURON DEGENERATION AND NEUROINFLAMMATION IN A CHRONIC MPTPP MODEL OF PARKINSON'S DISEASE
    in 9th FENS Forum of Neuroscience, Milano, 5-9 Luglio
    (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori
  • P. Porceddu(1), A. Pinna(2), L. Frau(1), M. Morelli(3) (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#url
  • http://fens2014.meetingxpert.net/FENS_427/poster_103575/program.aspx (literal)
Note
  • Abstract (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni
  • 1)Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy ; (2)CNR, Institute of Neuroscience, Cagliari, Italy ; (3)Department of Biomedical Sciences, University of Cagliari. CNR Institute of Neuroscience. INN-National Institute of Neuroscience, Cagliari, Italy (literal)
Titolo
  • EFFICACY OF RASAGILINE ON PROGRESSIVE DOPAMINE NEURON DEGENERATION AND NEUROINFLAMMATION IN A CHRONIC MPTPP MODEL OF PARKINSON'S DISEASE (literal)
Abstract
  • Aims: Parkinson?s Disease (PD) is characterized by a chronic progressive loss of nigrostriatal dopaminergic neurons, associated to chronic neuroinflammation. The MAO-B inhibitors have neuroprotective activity in cellular and animal models of neurodegenerative disorders, as PD. In particular, rasagiline has a neurorestorative activity in degeneration of nigrostriatal dopamine neurons induced by acute MPTP treatment. In the present study we have evaluated the efficacy of rasagiline on neurodegeneration and neuroinflammation in a chronic mice model of MPTP administration which induce a progressive loss of nigrostriatal dopaminergic neurons and astroglia and microglia activation. Methods: Mice were treated with vehicle, or MPTP plus probenecid administered twice a week for 5 weeks, alone or in the presence of rasagiline administered 18 hrs before each MPTP administration. After treatment, the motor performance of mice was evaluated by the beam-walking test. Dopamine neuron degeneration and glial reactivity were measured by immunohistochemical evaluation of tyrosine hydroxylase (TH)-positive neurons and by CD11b (microglia) and GFAP (astroglia) in striatum and in substantia nigra pars-compacta (SNc). Results: Chronic MPTP induced an impairment of motor performance, a decrease in dopamine neurons in striatum and SNc, and an increase of astroglia and microglia. Previous administration of rasagiline decreased MPTP-induced motor deficits, as well as dopamine neuron degeneration and CD11b and GFAP activation. Conclusions: The inhibition of MAO-B with rasagiline showed neuroprotective efficacy in a model that more closely reproduce neurodegeneration in PD in which the dopamine neuron degeneration takes place over time.; (literal)
Prodotto di
Autore CNR

Incoming links:


Autore CNR di
Prodotto
data.CNR.it